Enzyme Inhibitors Market By Industry 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Enzyme Inhibitors Market
Enzyme Inhibitors Market: By Industry (Pharmaceutical Industry, Agrochemical Industry), By Application (Drug Development, Diagnostic Agent, Pesticide Synthesis & Others) & By Region-Forecast (2016-2021)
Report Code : HCR 0289
Updated Date: 24 February, 2016   20% discount on this report

  • Report Description
  • Table of Contents
  • Customization Options
Enzyme Inhibitors is a molecule which acts by binding to an enzyme reversibly or irreversibly and decreasing or completely inhibiting its catalytic activity. Enzyme inhibitors are made up of protein and they occur naturally. Since blocking an enzyme's activity alter a biochemical process and cause imbalance which may terminate and/or slow down a process. Enzymes are involved in metabolism they regulate various metabolic pathways. In insects and some animals natural enzyme inhibitors are produced and are used as defense system against predators. Majority of drugs to treat a number of chronic and/or life-threatening diseases are developed with a mechanism of action directed towards enzyme inhibition. Enzyme specificity and potency are the important factors considered while developing a drug. A high specificity and potency ensures that a drug will have few side effects and strong therapeutic effect. Also, enzyme inhibitors are used as diagnostic agent to screen various diseases.

Factors driving global demand for Enzyme Inhibitors are its wide applications in pharmaceutical, agrochemical industries. Restraining factors for enzyme inhibitor market is patent expiry of various drugs.

This report provides information on enzyme inhibitors market size for the year 2014-2016, and forecast of the same for year 2021. It also focuses on market drivers, challenges, restraints, market dynamics, growth indicators, competitive landscape, potential growth opportunities and other key aspects with respect to enzyme inhibitors market.
 
Enzyme Inhibitors Market

The market for enzyme inhibitors is expanding with the rising incidence of enzyme based diseases and increasing research and development activities. In developed countries like US, Europe the market growth for enzyme inhibitor is high because of better diagnosis rate for the diseases, availability of medical facility, infrastructure, awareness and available treatment options. In Asia pacific region Japan, china and India are most potential markets due to economic development, improvement in medical facilities and growing population.

This report identifies global enzyme inhibitor market on the basis of application and regional market as follows:
  • Enzyme inhibitor market is segmented based on application. In drug development, as a diagnostic agent and to synthesize pesticides
  • This report is further segmented based on potential markets for enzyme inhibitors. A detailed analysis by region – North America, Europe, Asia Pacific (APAC) and Rest of the World (RoW), has been provided in this report
Sample Companies Profiled in this Report are:
  • Ranbaxy Laboratories Ltd
  • AstraZeneca
  • Merck
  • Pfizer 
  • Roche
  • 10+
1. Enzyme Inhibitors – Market Overview
2. Executive Summary
3. Enzyme Inhibitors Market - Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End User Profiling
      3.2.3. Top 5 Financials Analysis
4. Enzyme Inhibitors Market- Market Forces
   4.1. Drivers
      4.1.1. Increased focus on R&D
   4.2. Restraints
      4.2.1. Patent expiry of major drugs
   4.3. Opportunities
   4.4. Challenges
   4.5. Porter’s Five Force Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Customers 
      4.5.3. Threat of New Entrants 
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Enzyme Inhibitors Market – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis 
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Enzyme Inhibitors Market, By application
   6.1. Pharmaceutical Industry
   6.2. Agrochemical Industry
7. Enzyme Inhibitors Market, By Geography
   7.1. Introduction
   7.2. North America
      7.2.1. US
      7.2.2. Canada
      7.2.3. Mexico
   7.3. Europe
      7.3.1. U.K.
      7.3.2. France
      7.3.3. Germany
      7.3.4. Italy
      7.3.5. Spain
      7.3.6. Rest of Europe
   7.4. Asia Pacific
      7.4.1. China
      7.4.2. South Korea
      7.4.3. Japan
      7.4.4. India
      7.4.5. Rest of Asia Pacific
   7.5. RoW
8. Market Entropy
   8.1. Expansion
   8.2. Technological Developments
   8.3. Merger & Acquisitions, and Joint Ventures
   8.4. Supply - Contract
9. Company Profiles (Introduction, Financials, Key Insights, Key Strategy, Product Portfolio, SWOT Analysis)
   9.1. Roche
   9.2. Ranbaxy Laboratories Ltd
   9.3. Merck KGaA
   9.4. Pfizer
   9.5. Novartis
   9.6. Takeda Pharma
   9.7. AstraZeneca
   9.8. Johnson & Johnson
   9.9. Eli Lilly
   9.10. Amgen
*More than 10 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
10. Appendix
   10.1. Abbreviations
   10.2. Sources
   10.3. Research Methodology
   10.4. Expert Insights
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll